FDA panel finds GE's imaging agent Datscan beneficial

08/11/2009 | Wall Street Journal, The

An FDA panel said GE Healthcare's Datscan, an imaging agent that helps identify neurological disorders, is safe to use in patients. Panel members said they would have preferred to have more information on whether the agent can pinpoint Parkinson's disease rather than only helping doctors localize it. The company plans to review data from patients who have used the product, an official said.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA